US Patent Issued to FIVE ELEVEN PHARMA, BIOMOLECULAR PROBES BIOTECHNOLOGY (BEIJING) on June 30 for "Radioactively labeled ligand for fibroblast activation protein-alpha imaging agent and preparation method therefor" (American, Chinese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,630, issued on June 30, was assigned to FIVE ELEVEN PHARMA INC (Philadelphia) and BIOMOLECULAR PROBES BIOTECHNOLOGY (BEIJING) Co. LTD (Beijing).

"Radioactively labeled ligand for fibroblast activation protein-alpha imaging agent and preparation method therefor" was invented by Hank F Kung (Philadelphia), Zhihao Zha (Beijing), Karl Ploessl (Philadelphia), Seok Rye Choi (Philadelphia) and David Alexoff (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "A radioactively labeled ligand for a fibroblast activation protein-alpha imaging agent and a preparation method therefor are provided. The radioactively labeled ligand for the fibroblast activ...